Kusurinomadoguchi, Inc. logo

Kusurinomadoguchi, Inc.

5592.T

JPXHealthcareMedical - Healthcare Information Services

Latest quote

¥2,715

+¥24.00 · +0.89%

Aug 25, 10:32 AM JST

5592.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comprehensive platform includes patient-facing services such as the EPARK drug counter, an online portal for locating and booking appointments at pharmacies, and the EPARK medicine notebook, which enables digital management of family prescriptions and reservation for medication dispensations. The company also offers a dedicated site facilitating telephone medical consultations for over-the-counter medicines, alongside a system allowing patients to select their preferred pharmacy for services, and provides online medication guidance as well as hospital-supported online consultations. For pharmacy operations and management, Kusurinomadoguchi delivers Health Tech Navi, an electronic medication history system, and the Care Daisy system, which integrates various recording tools and ICT devices. It further provides procurement solutions for pharmaceuticals, including a marketplace for dispensing pharmacies to efficiently buy and sell surplus or slow-moving inventory, extending to the management and acquisition of otherwise stagnant stock. The firm also features a centralized management system to streamline outpatient reception, appointment scheduling, and online medical treatments. Additionally, it offers Pharmacy Support, a robust customer relationship management (CRM) system tailored for engaging repeat patients, alongside specialized operational systems for dispensing pharmacies and a matching service connecting nursing care facilities with appropriate pharmacies.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
JP
CEO
Nobuaki Tanaka
Listed since
Oct 4, 2023
Employees
491

Market position

Day range

Current ¥2,715

52-week range

Current ¥2,715

Open
¥2,691
Previous close
¥2,691
Volume
37.5K
0.44× average
Average volume
85.65K
Average daily volume
Market cap
31.11B JPY
Beta
0.83
Market reference 1
50-day average
¥2,451.16
+10.76% above average
200-day average
¥2,643.09
+2.72% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
24.99B JPY
P/E (TTM)
9.59×
P/B (TTM)
2.74×
P/S (TTM)
2.38×
EV / EBITDA
5.97×
Earnings yield
10.79%
Free cash flow yield
10.71%
Dividend yield
1.40%

Profitability & efficiency

Gross margin
56.52%
Operating margin
21.72%
Net margin
24.42%
Return on equity
26.01%
Return on assets
16.57%
Return on invested capital
18.36%

Financial health

Debt / equity
0.25×
Current ratio
1.94×
Altman Z-score
4.72
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends63%42%21%0%Gross margin, FY2021: 51.97%Gross margin, FY2022: 54.91%Gross margin, FY2023: 56.56%Gross margin, FY2024: 57.82%Gross margin, FY2025: 56.53%Operating margin, FY2021: 11.02%Operating margin, FY2022: 14.15%Operating margin, FY2023: 15.71%Operating margin, FY2024: 17.47%Operating margin, FY2025: 21.75%Net margin, FY2021: 7.95%Net margin, FY2022: 5.28%Net margin, FY2023: 9.99%Net margin, FY2024: 18.17%Net margin, FY2025: 23.95%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 51.97%. Gross margin FY2022 54.91%. Gross margin FY2023 56.56%. Gross margin FY2024 57.82%. Gross margin FY2025 56.53%. Operating margin FY2021 11.02%. Operating margin FY2022 14.15%. Operating margin FY2023 15.71%. Operating margin FY2024 17.47%. Operating margin FY2025 21.75%. Net margin FY2021 7.95%. Net margin FY2022 5.28%. Net margin FY2023 9.99%. Net margin FY2024 18.17%. Net margin FY2025 23.95%.

Income trends

Revenue

12.33B JPY+10.10%

Operating income

2.68B JPY+37.06%

Net income

2.95B JPY+45.10%
Income trends across reported periods13.52B JPY8.75B JPY3.97B JPY−802.41M JPYRevenue, FY2021: 6.49B JPYRevenue, FY2022: 7.42B JPYRevenue, FY2023: 8.72B JPYRevenue, FY2024: 11.2B JPYRevenue, FY2025: 12.33B JPYOperating income, FY2021: 715.03M JPYOperating income, FY2022: 1.05B JPYOperating income, FY2023: 1.37B JPYOperating income, FY2024: 1.96B JPYOperating income, FY2025: 2.68B JPYNet income, FY2021: 515.61M JPYNet income, FY2022: 391.45M JPYNet income, FY2023: 870.92M JPYNet income, FY2024: 2.03B JPYNet income, FY2025: 2.95B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 6.49B JPY. Revenue FY2022 7.42B JPY. Revenue FY2023 8.72B JPY. Revenue FY2024 11.2B JPY. Revenue FY2025 12.33B JPY. Operating income FY2021 715.03M JPY. Operating income FY2022 1.05B JPY. Operating income FY2023 1.37B JPY. Operating income FY2024 1.96B JPY. Operating income FY2025 2.68B JPY. Net income FY2021 515.61M JPY. Net income FY2022 391.45M JPY. Net income FY2023 870.92M JPY. Net income FY2024 2.03B JPY. Net income FY2025 2.95B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue12.33B JPY11.2B JPY8.72B JPY7.42B JPY6.49B JPY
Cost of goods sold5.36B JPY4.72B JPY3.79B JPY3.35B JPY3.12B JPY
Gross profit6.97B JPY6.48B JPY4.93B JPY4.07B JPY3.37B JPY
Selling, general, and administrative4.29B JPY4.52B JPY3.56B JPY3.02B JPY2.66B JPY
Operating expenses4.29B JPY4.52B JPY3.56B JPY3.02B JPY2.66B JPY
Interest income6.3M JPY5.12M JPY
Interest expense13.43M JPY5.9M JPY8.39M JPY9.68M JPY32.82M JPY
Depreciation and amortization1.5B JPY1.31B JPY1.03B JPY833.4M JPY676.44M JPY
Operating income2.68B JPY1.96B JPY1.37B JPY1.05B JPY715.03M JPY
Net income2.95B JPY2.03B JPY870.92M JPY391.45M JPY515.61M JPY

Company facts updated Aug 25, 2026.

Earnings

Latest EPS result
54.43

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates117.0586.2555.4524.64Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 28.99, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 91.46, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 42.61, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual 34.47, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 110.53, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 44.36, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 73.87, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 54.43, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.79B3.4B3.02B2.63BQ1 '25No estimateQ2 '25No estimateQ3 '25No estimateQ4 '25No estimateQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 14, 2025: actual 2.98B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 2.78B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual 2.91B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 2.91B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 3.1B JPY, estimate 3.23B JPY, surprise -3.87%, Miss. Q2 2026, reported May 14, 2026: actual 3.4B JPY, estimate 3.38B JPY, surprise +0.83%, Beat. Q3 2026, reported Aug 14, 2026: actual 3.64B JPY, estimate 3.4B JPY, surprise +7.15%, Beat. Q4 2026, reported Nov 12, 2026: actual —, estimate 3.4B JPY, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

DividendUpcoming

Ex-dividend Mar 30, 2027

¥40.00

Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥38.00

Annual

Record Mar 31, 2026 · Payment Jun 12, 2026

Dividend

Ex-dividend Mar 28, 2025

¥27.00

Annual

Record Mar 31, 2025 · Payment Jun 10, 2025

5592.T peers

Continue in GoAI

Research 5592.T

research.disclaimer